Anterior segment dysgenesis and early-onset glaucoma in nee mice with mutation of Sh3pxd2b

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 5, 2011, Pages 2679-2688

  Mao, Mao ^a   Buenz, Adam Hedberg ^a   Koehn, Demelza ^a   John, Simon W M ^b   Anderson, Michael G ^a  

^a UNIVERSITY OF IOWA   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; SH3PXD2B PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; ANTERIOR EYE SEGMENT DYSGENESIS; AQUEOUS HUMOR OUTFLOW; ARTICLE; CELL LOSS; CONTROLLED STUDY; CORNEA DISEASE; CORNEA OPACITY; DISEASE COURSE; EARLY ONSET GLAUCOMA; EYE DEVELOPMENT; EYE MALFORMATION; GENE MUTATION; GLAUCOMA; HISTOLOGY; INTRAOCULAR PRESSURE; IRIS DISEASE; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NEE MOUSE; NONHUMAN; ONSET AGE; OPTIC NERVE; PRIORITY JOURNAL; RETINA GANGLION CELL; SLIT LAMP;

AGE OF ONSET; ANIMALS; EYE ABNORMALITIES; GLAUCOMA; INTRAOCULAR PRESSURE; MICE; MICE, MUTANT STRAINS; OPTIC NERVE DISEASES; PHOSPHOLIPID TRANSFER PROTEINS;

EID: 79956042362     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5993     Document Type: Article

References (73)

1. Kwon YH, Fingert JH, Kuehn MH, Alward WL. Primary open-angle glaucoma. N Engl J Med. 2009;360:1113-1124.
2. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
3. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713; discussion 829-730.
4. McKinnon SJ, Goldberg LD, Peeples P, Walt JG, Bramley TJ. Current management of glaucoma and the need for complete therapy. Am J Manag Care. 2008;14:S20-S27.
5. Allingham RR, Liu Y, Rhee DJ. The genetics of primary open-angle glaucoma: a review. Exp Eye Res. 2009;88:837-844.
6. Wiggs JL. Genetic etiologies of glaucoma. Arch Ophthalmol. 2007; 125:30-37.
7. Tumer Z, Bach-Holm D. Axenfeld-Rieger syndrome and spectrum of PITX2 and FOXC1 mutations. Eur J Hum Genet. 2009;17:1527-1539.
8. Dai JX, Johnson RL, Ding YQ. Manifold functions of the Nail-Patella Syndrome gene Lmx1b in vertebrate development. Dev Growth Differ. 2009;51:241-250.
9. Morales J, Al-Sharif L, Khalil DS, et al. Homozygous mutations in ADAMTS10 and ADAMTS17 cause lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature. Am J Hum Genet. 2009;85:558-568.
10. Azzedine H, Bolino A, Taieb T, et al. Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am J Hum Genet. 2003;72:1141-1153.
11. Dundar M, Saatci C, Tasdemir S, Akcakus M, Caglayan AO, Ozkul Y. Frank-ter Haar syndrome with unusual clinical features. Eur J Med Genet. 2009;52:247-249.
12. Frank Y, Ziprkowski M, Romano A, et al. Megalocornea associated with multiple skeletal anomalies: a new genetic syndrome? J Genet Hum. 1973;21:67-72.
13. Iqbal Z, Cejudo-Martin P, de Brouwer A, et al. Disruption of the podosome adaptor protein TKS4 (SH3PXD2B) causes the skeletal dysplasia, eye, and cardiac abnormalities of Frank-Ter Haar Syndrome. Am J Hum Genet. 2010;86:254-261.
14. Hishida T, Eguchi T, Osada S, Nishizuka M, Imagawa M. A novel gene, fad49, plays a crucial role in the immediate early stage of adipocyte differentiation via involvement in mitotic clonal expansion. FEBS J. 2008;275:5576-5588.
15. Buschman MD, Bromann PA, Cejudo-Martin P, Wen F, Pass I, Courtneidge SA. The novel adaptor protein Tks4 (SH3PXD2B) is required for functional podosome formation. Mol Biol Cell. 2009; 20:1302-1311.
16. Gimona M, Buccione R, Courtneidge SA, Linder S. Assembly and biological role of podosomes and invadopodia. Curr Opin Cell Biol. 2008;20:235-241.
17. Aga M, Bradley JM, Keller KE, Kelley MJ, Acott TS. Specialized podosome-or invadopodia-like structures (PILS) for focal trabecular meshwork extracellular matrix turnover. Invest Ophthalmol Vis Sci. 2008;49:5353-5365.
18. Mao M, Thedens DR, Chang B, et al. The podosomal-adaptor protein SH3PXD2B is essential for normal postnatal development. Mamm Genome. 2009;20:462-475.
19. Lively GD, Jiang B, Hedberg-Buenz A, et al. Genetic dependence of central corneal thickness among inbred strains of mice. Invest Ophthalmol Vis Sci. 2010;51:160-171.
20. John SW, Hagaman JR, MacTaggart TE, Peng L, Smithes O. Intraocular pressure in inbred mouse strains. Invest Ophthalmol Vis Sci. 1997;38:249-253.
21. Smith RS, Zabaleta A, John SW, et al. General and special histopathology. In: Smith RS, ed. Systemic Evaluation of the Mouse Eye. Boca Raton, FL: CRC Press; 2002:265-297.
22. Anderson MG, Libby RT, Mao M, et al. Genetic context determines susceptibility to intraocular pressure elevation in a mouse pigmentary glaucoma. BMC Biol. 2006;4:20.
23. Trantow CM, Hedberg-Buenz A, Iwashita S, Moore SA, Anderson MG. Elevated oxidative membrane damage associated with genetic modifiers of Lyst-mutant phenotypes. PLoS Genet. 2010;6: e1001008.
24. Anderson MG, Smith RS, Savinova OV, et al. Genetic modification of glaucoma associated phenotypes between AKXD-28/Ty and DBA/2J mice. BMC Genet. 2001;2:1.
25. Bayer AU, Neuhardt T, May AC, et al. Retinal morphology and ERG response in the DBA/2NNia mouse model of angle-closure glaucoma. Invest Ophthalmol Vis Sci. 2001;42:1258-1265.
26. Gould DB, Marchant JK, Savinova OV, Smith RS, John SW. Col4a1 mutation causes endoplasmic reticulum stress and genetically modifiable ocular dysgenesis. Hum Mol Genet. 2007;16:798-807.
27. Gould DB, Phalan FC, Breedveld GJ, et al. Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science. 2005;308:1167-1171.
28. Noguchi T, Sugisaki T, Kudo M, Satoh I. Retarded growth of the suprachiasmatic nucleus and pineal body in dw and lit dwarf mice. Brain Res. 1986;391:161-172.
29. Drager UC. Birth dates of retinal ganglion cells giving rise to the crossed and uncrossed optic projections in the mouse. Proc R Soc Lond B Biol Sci. 1985;224:57-77.
30. Linden R, Pinto LH. Developmental genetics of the retina: evidence that the pearl mutation in the mouse affects the time course of natural cell death in the ganglion cell layer. Exp Brain Res. 1985;60:79-86.
31. Strom RC, Williams RW. Cell production and cell death in the generation of variation in neuron number. J Neurosci. 1998;18: 9948-9953.
32. Young RW. Cell death during differentiation of the retina in the mouse. J Comp Neurol. 1984;229:362-373.
33. Dangata YY, Kaufman MH. Myelinogenesis in the optic nerve of (C57BL x CBA) F1 hybrid mice: a morphometric analysis. Eur J Morphol. 1997;35:3-17.
34. Dangata YY, Findlater GS, Kaufman MH. Postnatal development of the optic nerve in (C57BL x CBA)F1 hybrid mice: general changes in morphometric parameters. J Anat. 1996;189:117-125.
35. Mabuchi F, Aihara M, Mackey MR, Lindsey JD, Weinreb RN. Regional optic nerve damage in experimental mouse glaucoma. Invest Ophthalmol Vis Sci. 2004;45:4352-4358.
36. Zhao X, Pearson KE, Stephan DA, Russell P. Effects of prostaglandin analogues on human ciliary muscle and trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2003;44:1945-1952.
37. Zhou M, Li XM, Lavker RM. Transcriptional profiling of enriched populations of stem cells versus transient amplifying cells: a comparison of limbal and corneal epithelial basal cells. J Biol Chem. 2006;281:19600-19609.
38. Luna C, Li G, Liton PB, Epstein DL, Gonzalez P. Alterations in gene expression induced by cyclic mechanical stress in trabecular meshwork cells. Mol Vis. 2009;15:534-544.
39. Steele MR, Inman DM, Calkins DJ, Horner PJ, Vetter ML. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest Ophthalmol Vis Sci. 2006;47:977-985.
40. Shi X, Cui B, Wang Z, et al. Removal of Hsf4 leads to cataract development in mice through down-regulation of gamma S-crystallin and Bfsp expression. BMC Mol Biol. 2009;10:10.
41. Fuchshofer R, Stephan DA, Russell P, Tamm ER. Gene expression profiling of TGFbeta2-and/or BMP7-treated trabecular meshwork cells: identification of Smad7 as a critical inhibitor of TGF-beta2 signaling. Exp Eye Res. 2009;88:1020-1032.
42. Hiura K, Lim SS, Little SP, Lin S, Sato M. Differentiation dependent expression of tensin and cortactin in chicken osteoclasts. Cell Motil Cytoskeleton. 1995;30:272-284.
43. Tarone G, Cirillo D, Giancotti FG, Comoglio PM, Marchisio PC. Rous sarcoma virus-transformed fibroblasts adhere primarily at discrete protrusions of the ventral membrane called podosomes. Exp Cell Res. 1985;159:141-157.
44. Yamaguchi H, Lorenz M, Kempiak S, et al. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol. 2005;168:441-452.
45. Abram CL, Seals DF, Pass I, et al. The adaptor protein fish associates with members of the ADAMs family and localizes to podosomes of Src-transformed cells. J Biol Chem. 2003;278:16844-16851.
46. Sato T, del Carmen Ovejero M, Hou P, et al. Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. J Cell Sci. 1997;110:589-596.
47. Gould DB, Smith RS, John SW. Anterior segment development relevant to glaucoma. Int J Dev Biol. 2004;48:1015-1029.
48. Sowden JC. Molecular and developmental mechanisms of anterior segment dysgenesis. Eye (Lond). 2007;21:1310-1318.
49. Gage PJ, Rhoades W, Prucka SK, Hjalt T. Fate maps of neural crest and mesoderm in the mammalian eye. Invest Ophthalmol Vis Sci. 2005;46:4200-4208.
50. Smith RS, Zabaleta A, Savinova OV, John SW. The mouse anterior chamber angle and trabecular meshwork develop without cell death. BMC Dev Biol. 2001;1:3.
51. Chang B, Smith RS, Peters M, et al. Haploinsufficient Bmp4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure. BMC Genet. 2001;2:18.
52. Kume T, Deng KY, Winfrey V, Gould DB, Walter MA, Hogan BL. The forkhead/winged helix gene Mf1 is disrupted in the pleiotropic mouse mutation congenital hydrocephalus. Cell. 1998;93:985-996.
53. Smith RS, Zabaleta A, Kume T, et al. Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant ocular development. Hum Mol Genet. 2000;9:1021-1032.
54. Weng J, Luo J, Cheng X, et al. Deletion of G protein-coupled receptor 48 leads to ocular anterior segment dysgenesis (ASD) through down-regulation of Pitx2. Proc Natl Acad Sci U S A. 2008;105:6081-6086.
55. Hjalt TA, Amendt BA, Murray JC. PITX2 regulates procollagen lysyl hydroxylase (PLOD) gene expression: implications for the pathology of Rieger syndrome. J Cell Biol. 2001;152:545-552.
56. Hassemer EL, Le Gall SM, Liegel R, et al. The waved with open eyelids (woe) locus is a hypomorphic mouse mutation in Adam17. Genetics. 2010;185:245-255.
57. Wordinger RJ, Fleenor DL, Hellberg PE, et al. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma. Invest Ophthalmol Vis Sci. 2007;48:1191-1200.
58. Fuchshofer R, Tamm ER. Modulation of extracellular matrix turnover in the trabecular meshwork. Exp Eye Res. 2009;88:683-688.
59. Alfandari D, Cousin H, Marsden M. Mechanism of xenopus cranial neural crest cell migration. Cell Adh Migr. 2010;4:553-560.
60. Faralli JA, Schwinn MK, Gonzalez JM, Jr., Filla MS, Peters DM. Functional properties of fibronectin in the trabecular meshwork. Exp Eye Res. 2009;88:689-693.
61. Hausman RE. Ocular extracellular matrices in development. Prog Retin Eye Res. 2007;26:162-188.
62. Crimaldi L, Courtneidge SA, Gimona M. Tks5 recruits AFAP-110, p190RhoGAP, and cortactin for podosome formation. Exp Cell Res. 2009;315:2581-2592.
63. Oikawa T, Itoh T, Takenawa T. Sequential signals toward podosome formation in NIH-src cells. J Cell Biol. 2008;182:157-169.
64. West-Mays JA, Pino G. Matrix Metalloproteinases as mediators of primary and secondary cataracts. Expert Rev Ophthalmol. 2007; 2:931-938.
65. Wong TT, Sethi C, Daniels JT, Limb GA, Murphy G, Khaw PT. Matrix metalloproteinases in disease and repair processes in the anterior segment. Surv Ophthalmol. 2002;47:239-256.
66. Danias J, Lee KC, Zamora MF, et al. Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57/BL6 mice. Invest Ophthalmol Vis Sci. 2003;44:5151-5162.
67. Fujikawa K, Iwata T, Inoue K, et al. VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans. PLoS One 5:e9050.
68. Harada T, Harada C, Nakamura K, et al. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J Clin Invest. 2007;117:1763-1770.
69. John SW, Smith RS, Savinova OV, et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci. 1998;39:951-962.
70. Mabuchi F, Lindsey JD, Aihara M, Mackey MR, Weinreb RN. Optic nerve damage in mice with a targeted type I collagen mutation. Invest Ophthalmol Vis Sci. 2004;45:1841-1845.
71. Zhou Y, Grinchuk O, Tomarev SI. Transgenic mice expressing the Tyr437His mutant of human myocilin protein develop glaucoma. Invest Ophthalmol Vis Sci. 2008;49:1932-1939.
72. Libby RT, Anderson MG, Pang IH, et al. Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis Neurosci. 2005;22:637-648.
73. McKinnon SJ, Schlamp CL, Nickells RW. Mouse models of retinal ganglion cell death and glaucoma. Exp Eye Res. 2009;88:816-824.